These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 648026)

  • 41. Immune deposits in Hodgkin's disease with nephrotic syndrome.
    Froom DW; Franklin WA; Hano JE; Potter EV
    Arch Pathol; 1972 Dec; 94(6):547-53. PubMed ID: 4117535
    [No Abstract]   [Full Text] [Related]  

  • 42. [Hodgkin's disease: biology can help the physician towards new prognostic factors and new therapeutic approaches].
    Rubio MT; Ghesquières H; Blay JY; Salles G
    Bull Cancer; 2001 Nov; 88(11):1081-90. PubMed ID: 11741802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of dialysable leukocyte extract on the mononuclear leukocytes in Hodgkin's disease.
    Lukács K; Kávai M; Berényi E; Frendl G; Schröder I; Szegedi G
    Haematologia (Budap); 1985; 18(2):105-13. PubMed ID: 3161810
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Level of circulating immune complexes in lymphogranulomatosis patients as a criterion of the status and prognosis of the disease].
    Savina NP
    Ter Arkh; 1986; 58(9):60-4. PubMed ID: 3787494
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Significance of immunocomplexes and complement in renal transplantation. Preliminary data].
    Schena FP; Pertosa G; Manno C; Losuriello V; Pastore A
    Minerva Chir; 1980 May; 35(10):709-14. PubMed ID: 7005726
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complement proteins and soluble immune complex levels in Nigerians having primary liver cell carcinoma.
    Salimonu LS; Olubuyide IO; Adeniran SO
    West Afr J Med; 1992; 11(2):100-5. PubMed ID: 1327086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cooperative binding of a complement component to antigen-antibody complexes. III. Complexes containing IgM antibodies.
    Kuo CY; Thompson JJ; Hoffmann LG
    Z Immunitatsforsch Immunobiol; 1976 Sep; 152(2):151-66. PubMed ID: 960974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complement deposition on immune complexes reduces the frequencies of metabolic, proteolytic, and superoxide oscillations of migrating neutrophils.
    Amit A; Kindzelskii AL; Zanoni J; Jarvis JN; Petty HR
    Cell Immunol; 1999 May; 194(1):47-53. PubMed ID: 10357880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hodgkin's disease associated with unusual immunological manifestations.
    Miró JM; Gatell JM; Llebaria C; Montserrat E; Garcia SanMiguel J
    Nouv Rev Fr Hematol (1978); 1982; 24(2):81-3. PubMed ID: 6213933
    [No Abstract]   [Full Text] [Related]  

  • 52. Measles infection. Involvement of the complement system.
    Charlesworth JA; Pussell BA; Roy LP; Robertson MR; Beveridge J
    Clin Exp Immunol; 1976 Jun; 24(3):401-6. PubMed ID: 939047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immune complexes associated with brain tumors: correlation with prognosis.
    Martin-Achard A; de Tribolet N; Louis JA; Zander E
    Surg Neurol; 1980 Mar; 13(3):161-3. PubMed ID: 7368063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The immunohistology of Hodgkin's disease--Reed-Sternberg cells and their variants.
    Angel CA; Warford A; Campbell AC; Pringle JH; Lauder I
    J Pathol; 1987 Sep; 153(1):21-30. PubMed ID: 3499498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Does the presence of HLA-B5 and B35 antigen signify a worse prognosis for Hodgkin's disease? Preliminary report].
    Prazák J; Hermanská Z
    Vnitr Lek; 1988 Mar; 34(3):270-6. PubMed ID: 3259347
    [No Abstract]   [Full Text] [Related]  

  • 56. [Assessment of the histologic type of Hodgkin's disease as a prognostic factor].
    Shust VF; Markochev AB; Skripkina NS
    Vopr Onkol; 1989; 35(10):1251-4. PubMed ID: 2596072
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Letter: Immune complexes in Hodgkin's disease.
    Kávai M; Berényi E; Pálkovi E; Szegedi G
    Lancet; 1976 Jun; 1(7971):1249. PubMed ID: 58301
    [No Abstract]   [Full Text] [Related]  

  • 58. Circulating immune complexes and complement in bancroftian filariasis.
    Nath G; Mohapatra TM; Sen PC
    Indian J Pathol Microbiol; 1991 Apr; 34(2):92-8. PubMed ID: 1752648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating immune complexes in Hodgkin's disease.
    Brown CA; Hall CL; Long JC; Carey K; Weitzman SA; Aisenberg AC
    Am J Med; 1978 Feb; 64(2):289-94. PubMed ID: 629278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating immune complexes and prognosis in human malignant lymphoma, a prospective study.
    Heier HE; Landaas TO; Marton PF
    Int J Cancer; 1979 Mar; 23(3):292-8. PubMed ID: 437911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.